EPL

EPL Opens Second Office on US West Coast

jeff — Thu, 26 Apr 2012 04:45:52 +0000

In response to a growing clientele in the western United States and Asia-Pacific region, Dr. Jeff Engelhardt has assumed the role of Vice President, West Coast Operations, effective April 1, 2012. Dr. Engelhardt will direct EPL’s further expansion into the region from an office located in Southern California. Dr. Engelhardt will be the primary contact for new and current clients in the region, and he will provide general pathology support (e.g., study pathologist, peer review, etc.), as well as pathology and regulatory consultation to clients requesting these services. Dr. Peter Mann will continue to serve as Manager of EPL Northwest from his office in Seattle, WA; together with Dr. Engelhardt, EPL will be able to be more responsive to our clients and enhance the unparalleled level of service expected of EPL. In order to allow Dr. Engelhardt to focus on this new area of responsibility, Dr. Jerry Hardisty has resumed his role as President of EPL. These organizational changes will ensure that EPL continues to be the premier histopathology services organization for the industry.

SOT 2012 Attendees

jeff — Fri, 09 Mar 2012 23:32:24 +0000

Welcome to San Francisco!

Stop by Booth 1436 to find out what’s new at EPL and register for our prize drawing.

The End of an Era

jeff — Wed, 15 Feb 2012 21:14:42 +0000

Cyndi Bono has retired from EPL after an illustrious career of more years than she will let us say. She has not left us completely, though, and will continue to arrange the EPL booth and receptions at meetings at least through the end of 2012. We miss her greatly around the office here in Sterling, but know she is never very far away.

Jeff Engelhardt

Value of Pathology Working Groups at EPL

cbono — Thu, 26 May 2011 18:53:32 +0000

Although a Sponsor can never know exactly how a regulatory authority will respond to toxicity data, there are great examples of how a Pathology Working Group (PWG) can be beneficial. Recently, the study pathologist for a mouse carcinogenicity study identified a relatively low number of renal tumors that raised the concern of the involved regulatory authority. A review of the tumors by an internationally renowned expert concluded that the neoplasms were spontaneous in origin and not due to the test article. A PWG composed of five prominent pathologists including the study pathologist and the expert was chaired by Dr. Jerry Hardisty and reaffirmed the findings and conclusions of the expert. The PWG report was submitted to the regulatory authority for their consideration. A response came that they reviewed the evidence presented in the PWG re-evaluation and concurred with the PWG that the renal neoplasms were not due to the test article. While an outcome like this cannot be guaranteed, the PWG was quite valuable in the decision in favor of the Sponsor.

If you have a need to resolve an issue or differences of opinion regarding pathology data from your toxicity studies, Contact Us

EPL CEO Receives Society of Toxicologic Pathology 2011 Achievement Award

unity — Thu, 14 Apr 2011 18:54:51 +0000

Dr. Jerry Hardisty, EPL CEO, has been chosen to receive the Society of Toxicologic Pathology 2011 Achievement Award. To quote the STP Executive Director…“This award is presented to an STP Member who has played critical and influential roles in the area of toxicologic pathology over an extended period of time and it is especially fitting that you should receive this award on STP’s 40^th anniversary.”

Watch for Monthly Updates from EPL President

unity — Wed, 13 Apr 2011 18:55:03 +0000

Watch for monthly updates from our President, Dr. Jeff Engelhardt, for happenings in the global regulatory environment and discussions on topics of interest for pathologists.

EPL is celebrating its 40th Anniversary

unity — Wed, 13 Apr 2011 18:53:05 +0000

EPL is celebrating its 40^th Anniversary this year. Thank you for your support and confidence over the years.